Giving Information on Medicinal Products to the General Public: In Search of a Definition to Safeguard the Patient

TY - JOUR

T1 - Giving Information on Medicinal Products to the General Public

T2 - In Search of a Definition to Safeguard the Patient

AU - Faeh, Andrea

PY - 2014

Y1 - 2014

N2 - Information on medicinal products is vital for enabling patients to give informed consent to the use of a specific product. Within the European Union (EU) the debate about how much information about prescription-only medicinal products should be made available to patients has gone on for the past five years with no definite conclusion yet. This contribution assesses the current legislation and the ongoing debate in order to identify the challenges and the prospect of new legislation, and consider its potential implications for the scope for advertising and for patient safety.

AB - Information on medicinal products is vital for enabling patients to give informed consent to the use of a specific product. Within the European Union (EU) the debate about how much information about prescription-only medicinal products should be made available to patients has gone on for the past five years with no definite conclusion yet. This contribution assesses the current legislation and the ongoing debate in order to identify the challenges and the prospect of new legislation, and consider its potential implications for the scope for advertising and for patient safety.

U2 - 10.1163/15718093-12341313

DO - 10.1163/15718093-12341313

M3 - Journal article

SN - 0929-0273

VL - 21

SP - 176

EP - 195

JO - European Journal of Health Law

JF - European Journal of Health Law

IS - 2

ER -